Aurélie Dumont

Polo-like Kinase 1: A Potential Therapeutic Option in Combination with Conventional Chemotherapy for the Management of Patients with Triple-Negative Breast Cancer

Virginie Maire, Fariba Némati, Marion Richardson et al. · Cancer Research · 2012 · 188 citations · Full text

Breast Oncology, Tnbc Cell Lines, Pathology +20

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer

Virginie Maire, Céline Baldeyron, Marion Richardson et al. · PLoS ONE · 2013 · 166 citations · Full text

Breast Oncology, Medicine, Pathology +12

Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells

Florence Sancier, Aurélie Dumont, Audrey Sirvent et al. · PLoS ONE · 2011 · 40 citations · Full text

Pathology, Specific Oncogenic Activity, Cancer Biology +19

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer

Émilie Le Rhun, Nicolas Bertrand, Aurélie Dumont et al. · European Journal of Cancer · 2017 · 38 citations · Full text

Pi3k-akt-mtor Pathway, Metastatic Breast Cancer, Cancer Risk +9

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers

Sylvie Maubant, Tania Tahtouh, Amélie Brisson et al. · Oncotarget · 2018 · 32 citations · Full text